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Abstract 
Background:  
The extent to which cortisol levels are elevated in major depressive episodes (MDE), and hence 
could act as a biomarker of illness, remains unclear.  Although patient characteristics may 
explain some of this variation – for example elevated cortisol being more often found in 
patients with severe, psychotic or melancholic depression – problems with the methods used 
to measure cortisol may also have contributed to the inconsistent findings. Fingernails are a 
novel sample that can be used to assess aggregate cortisol concentrations over a 15-day period, 
and may provide a more accurate reflection of longer term cortisol level changes in MDE and 
help clarify this issue. This methodology has not yet been utilised in MDE.    
Methods: Cortisol levels reflecting a period of 15 days were measured using fingernails in a 
group of 26 subjects experiencing a major depressive episode (MDE) and in an age and gender 
matched group of 45 healthy controls. 
Results: Depressed subjects showed significantly higher mean cortisol levels measured in 
fingernails when compared with control subjects. Higher levels of cortisol were associated with 
higher depression severity scores, a diagnosis of non-reactive depression, and more prominent 
melancholic symptoms. Conversely, fatigue was negatively correlated with cortisol levels. 
Conclusion: There is elevated cortisol in MDE when assessed using an aggregate measure 
over two weeks. Alterations in fingernail cortisol correlate with key clinical symptoms and 
subtypes of depression.  
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Introduction 
Hypercortisolaemia is considered a candidate biomarker potentially able to support the 
diagnosis or sub-typing of the major depressive disorder at biological level (Pariante 2009). 
However, there is some inconsistency in this finding, especially when using short-term 
measurements of cortisol concentrations such as salivary cortisol. This may be, in part, 
explained by the large heterogeneity seen within depressive syndromes. Indeed, it has been 
shown that depressive episodes with psychotic or melancholic features (Carroll et al., 2007, 
2012; Schatzberg et al., 2002), largely account for the increased cortisol levels found in this 
disorder. Furthermore, this could be also due to the susceptibility of these parameters to the 
influence of state variables, such as the day of the week, time of day or presence of transient 
extraneous factors liable to alter levels such as stress (Kudielka & Wüst, 2010). Fingernails, an 
integumentary type of tissue that share several properties with hair (Herane-Vives et al., 2017), 
have recently been used and validated for measuring longer-term concentrations of cortisol 
(Ben Khelil et al. 2011; Izawa et al. 2015). The advantages of this methodology are manifold: 
it is non-invasive, economical in that repeated sampling can be avoided, and enables the 
assessment of cumulative cortisol concentrations over an extended period of time. To date, 
only one study has used this specimen in the mental health field for this purpose (Warnock et 
al. 2010) and none in subjects with major depression. Based on the background mentioned 
above, we designed this study with the objective to (1) compare fingernail cortisol 
concentrations in depressed subjects and matched healthy controls and (2) assess whether 
differences in cortisol levels are influenced by clinical variables in subjects with major 
depression. We hypothesised that subjects with major depressive episodes would be 
characterised by higher fingernail cortisol levels than healthy controls. 
 
Methods 
 Participants 
Participants were recruited as part of an ongoing collaboration between London (UK), Santiago 
(Chile) and Hong Kong. Depressed participants were recruited via public advertisements (Wise 
et al. 2016) and from local psychological therapy and secondary care services. Twenty-six 
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depressed patients were recruited, twenty in London (UK), six in Santiago (Chile) and none in 
Hong Kong.  All psychometric tools were English or validated Spanish/Chinese versions. 
Patients met DSM-IV criteria for a major depressive episode (MDE) in the context of either a 
unipolar or bipolar disorder, diagnosed using the Mini-International Neuropsychiatric 
Interview (MINI) (Sheehan et al. 1998) and reported no history of psychiatric illness in first 
degree relatives. Depression severity was assessed with the Hamilton Depression Rating Scale 
(HAMD-17, Hamilton 1967) with only those scoring at clinical severity (≥ 13) included (Cleare 
et al 2015). Rating of depressive symptoms across sites was evaluated on an independent set 
of patients and showed a high inter-rater reliability (Intraclass correlation coefficient=0.96, 
p=0.004). The Quick Inventory of Depressive Symptoms was used as a self-rated measure of 
depressive symptoms (Rush et al, 1993). The Young Mania Rating Scale (Young et al. 1978) 
was used to exclude current hypomania/mania, while historical self-reported hypomanic 
symptoms were assessed using the 33-item hypomania checklist (HCL-33) (Feng et al. 2016). 
Melancholic symptoms of depression were assessed using the Newcastle Depression 
Diagnostic scale (NDDS, Carney et al. 1965) and atypical depression with the Atypical 
Depression Diagnosis Scale (ADDS, Stewart et al 1993). This latter scale provides four 
categories: (1) ‘non-reactive depression’, (2) ‘simple reactive depression’, (3) ‘probable 
atypical depression’ and (4) ‘a definite atypical depression’. The presence of rumination and 
irritability symptoms was established by using the Rumination Scale (Treynor et al. 2003) and 
the Self-Assessment of Irritability Scale (Snaith et al. 1978). Anxious symptoms were assessed 
using the “Anxiety Factor” on the 17-item HAMD-17 (Levitt et al. 1993). Environmental 
factors in the three months prior to study participation were assessed using the Hassles Scale 
(Kanner & Coyne 1981) and the Recent Life Changes Questionnaire (Miller & Rahe 1997), 
while early life trauma was assessed with the Childhood Trauma Questionnaire (CTQ; 
Bernstein et al. 1994). The presence of childhood trauma was recorded if a participant 
presented with a score greater than the threshold on any of the following subscales of the CTQ: 
emotional abuse (threshold >12), physical abuse (threshold >9), sexual abuse (threshold >7), 
emotional neglect (threshold >14) and physical neglect (threshold >9). Patients were 
medication free for ≥2 weeks (≥4 weeks for fluoxetine) and were not receiving any 
psychological intervention at the time of the assessment. Healthy controls were free from 
current or past psychiatric diagnoses as assessed using the MINI, as were their first-degree 
relatives using patient history. Participants were excluded if they reported any illicit substance 
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use in the previous three months or had any unstable medical condition. Healthy controls were 
free from current or past psychiatric diagnoses as assessed using the MINI, and reported no 
history of psychiatric illness in first degree relatives. Participants were excluded if they 
reported any illicit substance use in the previous three months or had any unstable medical 
condition. Controls (n=45) were recruited from public advertisements and from hospital and 
university staff across the three sites from UK (n=15), Chile (n=2) and Hong Kong (n=28). The 
over recruitment of controls from Hong-Kong was undertaken in order to increase the statistical 
power of the study.  Controls were selected in order to match as closely as possible in age and 
gender with the depressed group. The local ethics committee approved the research and written 
informed consent was obtained from each participant. All participants received modest 
compensation for taking part in the research. 
Fingernail specimens  
Participants were instructed to clip their fingernails 15 days prior to the study assessment day 
in order to standardise the number of days’ growth to be sampled (approximately 1.5 mm per 
nail). Subjects were provided with detailed instruction on how to cut their fingernails accurately 
at the desired length at the 15-day time point, store the samples correctly and post them in 
specific containers back to the investigators. Cortisol was subsequently extracted according to 
the method described by Warnock and others (2010), with minor modifications. 
 
Fingernails extraction 
Fingernail samples were washed two times with 3 ml isopropanol (LC/MS grade) in glass vials 
and dried overnight. Next, 20-50 mg of the washed clippings were ground (Retsch ball mill 
mixer; 30 Hz) and 10-25 mg of accurately weighed specimen was used for cortisol extraction 
(1.5 ml LC/MS methanol; 1 hour on rotary mixer). Finally, after centrifugation, 1.3 ml of the 
methanol supernatant was transferred to a separate tube and evaporated to dryness at 60-degree 
Celsius under nitrogen. The residue was redissolved in 1 ml of assay buffer and stored at -30 
degree Celsius until Immunoassay (Mondelli et al. 2010). All fingernail samples were analysed 
in the Affective Disorders Laboratory at the Bethlem Royal Hospital, London UK.  
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Statistical analysis  
Data were checked for normality using graphic methods, such as histograms, and the 
Kolmogorov-Smirnov statistical test; results indicated that the fingernail cortisol data were not 
normally distributed (Figure 1).  Therefore, we used a non-parametric test (Mann-Whitney U 
test) to compare fingernail concentration between MDE participants and healthy controls and 
the Kruskal–Wallis test when cortisol values were compared in more than two groups. 
Demographic and clinical data were compared using parametric statistical tests (t tests) for 
continuous variables and Chi-squared for categorical variables. Finally, a regression model was 
created to estimate the regression coefficient (β) and 95% confidence intervals (CI) of the 
variance in cortisol levels in fingernails in relation to clinical and demographic continuous and 
categorical predictors in MDE participants. We used Generalised Linear Models (GLMs) with 
a gamma distribution and a log-link function to model the data so as to better take into account 
the right-skew in the hormone concentrations in the tissue. The GLM is a flexible 
generalization of ordinary linear regression that allows for response variables that have error 
distribution models other than a normal distribution (Nelder et al 1972). The level of 
significance was set at p≤0.05 (two-tailed). 
 
Results 
Detailed demographic and clinical variables of the sample are presented in Table 1. Twenty-
six subjects with a MDE including one patient with bipolar disorder type I and two with bipolar 
disorder type II took part in the research and were sex and age matched with 45 healthy 
controls. Twenty depressed patients were recruited in London (UK), six in Santiago (Chile) 
and none in Hong Kong. None of the patients showed significant current hypomanic symptoms.  
Eleven subjects met criteria for atypical depression (42%) whereas 15 were considered non-
atypical (59%), based on the ADDS scale. As predicted, patients differed from controls on a 
number of clinical parameters including symptoms of depression and anxiety, ruminative 
thinking style, and early life and current environmental factors. There was no difference in the 
length of fingernail samples, waist circumference, or Body Mass Index (BMI) between groups. 
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Fingernail cortisol level in depressed subjects vs. healthy controls 
Depressed subjects had significantly higher fingernail cortisol concentrations (FCC) (mean 
[SD]=201.2 [277.3] pg/mg, median [interquartile range, IQR]=96.4 [60.2–396.8 pg/mg]) in 
comparison to controls subjects using the Mann-Whitney U-test (mean [SD]=101.5 [90.5], 
median [IQR]=76.9 [39.2–165.6 pg/mg]; p=0.03). However, when we ran a sensitivity analysis 
excluding the 3 patients with bipolar disorder the difference between MDE and controls 
decreased to a trend level (p=0.09). There was no significant difference in FCC between 
different sites. FCC values for UK depressed participants were: mean [SD]=176.4 [235.9] 
pg/mg, median [IQR]=94.1 [70.1–154.8 pg/mg] and for Chilean depressed subjects were: mean 
[SD]=193.6 [268.3], median [IQR]=96.4 [77.5–160.8 pg/mg]; p=0.27 using the Mann-Whitney 
U-test. FCC values for control subjects were: UK: mean [SD]=142.6 [194.8] pg/mg, median 
[IQR]=88.8 [62.9–121.3 pg/mg], Chile: mean [SD]=100.0 [85.3], median [IQR]=84.6 [62.0–
105.3 pg/mg]; and Hong-Kong: mean [SD]=101.5 [90.5], median [IQR]=76.9 [62.0–105.4 
pg/mg]; p=0.29 using the Kruskal–Wallis -test. 
Regression analyses of fingernail cortisol levels with clinical variables 
The generalised linear model showed that higher levels of cortisol were associated with higher 
depression severity scores, a diagnosis of non-reactive depression, and more prominent 
melancholic symptoms (all p<0.05; Table 2). Conversely, lower levels of cortisol were 
associated with more severe fatigue (p<0.05; Table 2). No other clinical variables exerted a 
significant effect on cortisol levels in comparison to healthy participants (all p > 0.05).    
Discussion 
In this study we set out to measure differences in cortisol levels in MDE by using a novel 
technique utilising fingernails, representing aggregate cortisol concentrations averaged over a 
period of 15 days. We demonstrated that fingernail cortisol concentration is increased overall 
in MDE compared with healthy controls. The GLM also showed that higher levels of cortisol 
were associated with higher depression severity scores, features of non-atypical depression, 
and more prominent melancholic symptoms. Conversely, more severe fatigue was associated 
with decreased cortisol levels. 
Medium-term cortisol levels 
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These results suggest that overall cortisol levels are elevated during an MDE when assessed 
cumulatively over a 15-day period. This provides additional evidence over and above findings 
of elevated shorter-term measures of cortisol such as blood, saliva and urine, and strengthens 
the position of elevated cortisol release as an important neurobiological correlate of depression 
(Pariante 2009). Further support for the elevation of cortisol over longer time frames comes 
from studies using hair specimens from depressed patients, which usually cover longer periods 
of around 3 months (Dettenborn et al. 2012; Herane Vives et al 2016, Wei et al. 2015, 
Pochigaeva, 2017).  
Clarification that raised cortisol is a persistent phenomenon, particularly in those with more 
severe forms of depression with typical features, suggests that some patients with depression 
manifest the same neurobiological disturbance as Cushing’s syndrome, but in a less severe 
form. Chronic hypercortisolism in Cushing syndrome has a variety of potentially deleterious 
effects, including obesity, hypertension, glucose intolerance, osteoporosis, impaired immune 
function, and poor wound healing (Pennacchietti 2015). However, the degree of 
hypercortisolism, when present in depression, is of a milder form compared to that Cushing’s 
syndrome. For example, one study found a median fingernail cortisol of 679 pg/mg in 
Cushing’s syndrome (Thomson et al. 2010), which is much higher than the median of 96.4 
pg/mg in the current study, notwithstanding that direct comparison is hampered by some 
differences in the techniques used. Nevertheless, several depressed individuals did have 
fingernail cortisol levels in the 200-1000 pg/mg range (see Fig 1) which are more similar to 
those seen in Cushing’s syndrome.  Overall, however, the level of cortisol measured in 
depressed subjects appears to fall within the range described as subclinical hypercortisolism 
(Dalmazi & Pasquali 2015). This condition has to date been generally been applied to subjects 
with ‘adrenal incidentalomas’ and not from depression. Given the potential impact of 
chronically elevated cortisol levels as demonstrated in fingernails, depression ought perhaps to 
be included within the remit of subclinical hypercortisolism.  
The occurrence of depressive recurrences would be expected to lead to repeated, periodical 
high level of cortisol (Mueller & Leon 1999).  This could potentially contribute to factors such 
as poorly controlled blood pressure (Bednarek & Jankowski 2014), raised glucose levels 
(Gillmer et al. 1975) and other more complex cardiovascular or metabolic condition often 
coexisting in subjects with subclinical hypercortisolism (Dalmazi & Pasquali, 2015) and 
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depression (Katon, 2003). Another possible correlate of elevated cortisol is that of persistent 
cognitive impairment, which is present in some depressed patients and has been found to affect 
most of the cognitive domains (Porter et al. 2003). If the impaired cognition in patients with 
histories of more severe depression is linked to hypercortisolism, this raises the possibility that 
drugs such as mifepristone, a specific glucocorticoid receptor blocker, may have a therapeutic 
benefit in this neurocognitive impairment (Young et al. 2004).  
Relation to depression sub-type 
We found that higher fingernail cortisol was associated with more severe depression, and with 
depressive episodes characterised by melancholic and non-reactive mood of depression.  This 
supports previous research suggesting that Hypothalamic–Pituitary–Adrenal (HPA) axis 
hyperactivity is more prominent in melancholic (Carroll & Feinberg 1981) and psychotic 
(Schatzberg et al. 2002) sub-types of depression. Therefore, elevated cortisol levels may be a 
potentially relevant biomarker particularly for those particular forms of depression. 
On the other hand, we did not find that fingernail cortisol was specifically linked to sub-type 
of atypical depression as the degree of broadly defined by the ADDS atypical symptomatology. 
Atypical depression has elsewhere been described to have lowered rather than elevated cortisol 
levels (Gold & Chrousos 2002). These previous studies assessed only short-term cortisol levels 
(Lamers et al. 2013; Gold & Chrousos 1999), and it is possible that hypocortisolaemia is not a 
chronic phenomenon in atypical depression.   
However, we did find that one of the features typically associated with atypical depression, 
severe fatigue, was negatively correlated with cortisol levels. Our results, therefore, provide 
new evidence that indicates that this somatic symptom is linked to lowered cortisol levels, not 
only in other disorders which have commonly been associated with low cortisol levels, such as 
Chronic Fatigue Syndrome (Cleare 2003), but also in affective disorders, such as MDE. It has 
been suggested that lowered cortisol may be an aetiological factor in CFS (Cleare 2004), given 
that low dose cortisol replacement can alleviate the experience of fatigue (Cleare et al 1999), 
which raises similar possibilities in patients with fatigue within affective disorders (Cleare 
2009).   
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Methods for assessing longer-term cortisol levels 
Cortisol measurement from fingernails presents a number of advantages over hair extraction, 
the other novel specimen recently introduced for measuring chronic cortisol levels over longer 
periods.  Specific confounding factors such as cosmetic treatment and frequency of washing 
for hair samples have not been found in fingernails, rendering results less susceptible to these 
extraneous factors, and facilitation easier matching of subject characteristics in case-control 
studies. Frequently, male subjects cannot be included in research using hair specimens because 
they are more likely to have a hair length shorter than three centimetres, the standard measure 
that these studies use (Dettenborn et al. 2010). Moreover, there remains a lack of agreement as 
to the optimal way to analyse hair samples (Pragst & Balikova 2006). Whilst some studies have 
ground hair before extracting cortisol, others have only cut them in small pieces (Davenport et 
al. 2006). The procedure of hair sampling can also have an aesthetic effect, leading potential 
subjects to avoid providing hair samples (Izawa et al. 2015).  In a recent community study, we 
found that 42% of subjects were unable to give hair due to shortness or baldness, while another 
29% refused to give hair for various reasons (Fischer et al, 2016). 
Limitations 
There are some methodological issues in this study worthy of discussion. First of all, a more 
complete description of cortisol changes in depression could have been achieved by including 
another specimen alongside fingernails.  This would have revealed any differences in cortisol 
levels in this group of patients assessed across different time periods. Nevertheless, we believe 
that the results using fingernails stand on their own and are an already validated method for 
measuring stable cortisol levels. Thus, fingernails have been demonstrated to be unaffected by 
acute influences (Izawa et al. 2015), a key requirement in order to reflect stable cortisol 
concentrations. Moreover, the use of fingernail cortisol has been validated in one recent study 
(Izawa et al. 2015) that found a positive and significant association between fingernail and hair 
cortisol levels – the latter being itself a now well-validated specimen for quantifying stable 
cortisol concentrations (D’Anna-Hernandez et al. 2011; Sauvé et al. 2007; Dettenborn et al. 
2010). Finally, the fact that fingernails share the same keratinized features as hair (Herane-
Vives et al. 2017) provides a theoretical underpinning of the results of Izawa et al (2015) 
suggesting that both specimens are likely to be reliable measures of chronic cortisol 
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concentrations. Nevertheless, we suggest that further larger studies comparing these two 
specimens may help reinforce these findings.  
We must also acknowledge that our recruitment of patients and controls was not evenly 
balanced between centres, introducing potential site heterogeneity and ethnic variation.  Whilst 
there is no evidence to date that fingernail cortisol differs between Asian and European or Latin 
cohorts, and we found no difference in our groups by centre of recruitment, an examination of 
ethnic differences was not a primary goal of the study.  Thus, it will be important for future 
studies to explicitly test whether there are subtle effects of ethnicity on fingernail cortisol 
measures, and for future studies of fingernail cortisol in depression to try to recruit a more 
homogeneous sample than we have done in order to eliminate possible confounding effects of 
centre or ethnicity.  
It is not clear why two specimens that have been validated for measuring chronic cortisol levels 
provide different levels of cortisol concentration. Indeed, several studies have detected an 
increased cortisol concentration in fingernails in comparison to hair samples (Raul et al. 2004; 
Ben Khelil et al. 2011), suggesting that any potential wash-out effect in fingernails has a smaller 
impact on cortisol concentrations than in hair. Nevertheless, the actual magnitude of the 
potential wash-out effect in cortisol fingernail levels has not yet been explicitly studied.  Wash 
out effects do play a clear role in diminishing cortisol concentration above the 3rd to 4th cm of 
hair (Kirschbaum et al. 2009). However, the average period of time assessed using fingernails 
in this study was equivalent to 0.61 cm of hair. Although it seems unlikely that there will have 
been a large washout effect in such a time period, we cannot definitively exclude this as it has 
not been studied for such short periods of time/short lengths of hair.  It is possible, therefore, 
that there is an additional early wash-out effect on the first millimetres of hair as soon as this 
specimen leaves the epidermis, after which cortisol concentrations then remains stable up to 
the three cm point, after which time other factors – such as UV radiation, shampoo or dye – 
exert an effect and decrease cortisol levels in hair.  
Another possible factor of relevance relates to the expression of hydroxysteroid (11-beta) 
dehydrogenase 2 (HSD-2), the enzyme that converts either cortisol to cortisone or cortisone to 
cortisol. In fact, while several studies have found that cortisone concentrations are similar in 
fingernails and hair (Raul et al. 2004; Ben Khelil et al. 2011), cortisol concentrations were 
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shown to be higher in fingernails (Ben Khelil et al. 2011) than in hair (Raul et al. 2004). It is 
possible, therefore, that hair-associated tissues, such as sweat glands (Raul et al. 2004) express 
larger amounts of HSD-2 in comparison to nail-associated tissues (e.g. the nail cuticle) leading 
to a differential cortisol/cortisone ratio in those tissues.  
However, this may prove to be less problematic than might first appear. Hair follicles are 
closely associated with two glands – the sebaceous gland and the apocrine gland. In scalp, the 
hair follicle and the sebaceous gland are fused both anatomically and functionally into what is 
called a pilosebaceous unit. But while the ducts of apocrine and sebaceous glands empty into 
the follicle, the ducts of eccrine glands, which are located near the follicles, do not empty into 
these structures but instead directly onto the skin surface. It means that, regardless of the 
amount of cortisol that these glands may deliver, this should be removed if this specimen is 
pre-washed with methanol before measuring cortisol inside the shaft, which is the cortisol 
which represents the systemic values (Grass et al. 2015). 
Another concern would be if the other potential sources of cortisol in hair, such as apocrine 
and sebaceous glands, overexpressed 11-β-HSD-2 in scalp relative to other tissues. However, 
we are not aware of any evidence that this is the case. Thus, it does not seem likely that 
differences in cortisol metabolising enzymes account for the observed differences in the 
amount of cortisol detected between hair and nail specimens. However, it seems more likely 
that other variables, such as differences in those mechanisms used by cortisol to cross cell 
membranes, may provide an explanation.  
First of all, it is important to highlight that for nails, in contrast to hair, no glandular elements 
are found in the cuticle or its surrounding tissues. Therefore, all cortisol accumulated in nails 
comes from the systemic circulation. In relation to this point, it has been shown that several 
lipophilic substances such as lead and arsenic among others, are deposited in nail after diffusing 
passively form blood (de Berker et al. 2007). Therefore, cortisol, being a lipophilic hormone, 
should not be an exception. This mechanism of transportation is observed when substances 
move across an area of higher concentration to lower concentration. This means that cortisol 
would diffuse more easily when its systemic value is high. These episodes can be clearly found 
in two circumstances: in generalised hypercortisolemic status, such as a primary Cushing’s 
syndrome or in some subtypes of depression, or during periods when momentary increases of 
Fingernail cortisol in depression 
 
13 
 
cortisol occur, such as those seen during early mornings. Thus, the physiology and histology 
of nails suggest that this specimen, instead of simply averaging daily cortisol outputs, as hair 
does, averages peaks of cortisol, at least in healthy people. In other words, nails preferentially 
accumulate cortisol when its concentration is high to freely diffuse from the systemic 
circulation. If this is the case, then our results may indicate that depressed outpatients have an 
increased medium-term cortisol reactivity levels in comparison to healthy people. 
In this article, we referred to the period of time over which cortisol is accumulated by 
fingernails as “medium-term”. We use this term since it is clear that we need to differentiate 
measures of acute cortisol levels, such as blood and saliva, from measures of chronic or 
averaged cortisol levels, such as hair and fingernails. However, it is also clear that the time-
frame covered by hair and fingernails differs; hair cortisol most commonly uses 3 cm of hair 
to represent the previous three months and fingernails (e.g. Warnock et al. 2010) the previous 
15 days, as we used here.  We wanted to choose a term that best encompasses this difference, 
and thus suggest using “medium-term” and “long-term”. We do consider that future research 
studies into cortisol changes in depression should focus on using short-, medium- and long-
term specimens, and that these may indeed measure different but complementary aspects of the 
disorder. 
Some limitations in the use of fingernails include possible effects on cortisol levels induced by 
nail growth rate, which can vary with seasonal changes, sex, different finger digits, clipping 
frequency, nail filing, and nail-biting habits (Gupta et al. 2005), although common cosmetic 
products such as nail varnish use are unlikely to affect fingernail cortisol (Ben Khelil et al. 
2011). Barker and others (2007) suggested that the length of fingernails is very important in 
relation to the concentration of cortisol extracted over a specific period of time. However, there 
were no differences in the length of fingernails between cases and controls in our sample, which 
indicates that the period covered by the nail specimens in this study was comparable between 
cases and controls. 
Future, larger studies using fingernails could compare more directly the degree of 
hypercortisolemia that depressed subjects present in comparison to subjects with clearly 
established hypercortisolism, such as those with Cushing’s syndrome, and link this to the 
presence of adverse metabolic and other physical effects. Studies using fingernails could also 
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investigate cortisol levels in other specific non-atypical subtypes of depression, such as those 
with DSM specifiers such as anxious-distress, melancholic or psychotic features. Future studies 
might also investigate whether chronic hypercortisolemia in fingernails is a specific finding of 
unipolar or bipolar depression; given the small number of MDE patients with longitudinal 
diagnoses of bipolar disorder in the current study we have been unable to do this. This analysis 
seems particularly important since the exclusion of the small number of patients with bipolar 
disorder decreased the difference in cortisol levels compared to controls from a significant to 
a trend level. Longitudinal studies may also be helpful in validating the pattern of cortisol 
secretion in relation to other features of depressive illness such as remission, relapse, chronicity 
and comorbidity. Prospective cohort studies in young people with depression could evaluate 
whether cortisol may play a causative role in the association between medical conditions, such 
as diabetes and heart disease, and depression. 
Conclusions 
The use of fingernails for measuring cortisol levels aggregated over 15 days showed that 
depressed outpatients as a whole have elevated medium-term cortisol levels in comparison to 
control subjects. The present results also suggest that patients with more severe depression, 
and with non-reactive and melancholic features, are particularly at risk of elevated cortisol, 
whereas levels may be relatively lower in patients with marked fatigue. The demonstration that 
cortisol levels may be elevated over a longer time frame than previous research suggests that 
some depressive episodes may be part of a group of conditions that have subclinical 
hypercortisolaemia. The potential role of these longer-term elevations of cortisol in medical 
conditions that occur at higher rates in depressed subjects needs to be further investigated.  
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Table 1: Demographic and clinical characteristics of the sample 
Demographic and Clinical 
Variables  
Healthy 
Controls 
Depressed 
Subjects 
P valuea       
N (F/M) 45 (24/21) 26 (19/7) 0.1 
Age (Years), Mean (SD) 39.0 (10.3) 38.1 (12.1) 0.73 
Number of previous episodes, Mean (SD) 0 (0) 2.6 (3.81) <0.01 
Duration of current episode (weeks), Mean 
(SD) 
0 (0) 90.2 (133.5) <0.01 
Number of admissions, Mean (SD) 0 (0) 0.17 (0.54) <0.01 
HAMD-17, Mean (SD) 0.4 (0.8) 19.0 (4.4) <0.01 
Anxiety Factor, Mean (SD) 0 (0) 5.8 (3.1) <0.01 
QIDS, Mean (SD) 0.4 (0.9) 17.9 (3.6) <0.01 
YMRS, Mean (SD) 0 (0) 0 (0) 1 
HCL-33, Mean (SD) 12.5 (8.0) 17.7 (5.4) 0.01 
NDDS, Mean (SD) 0 (0) 3.3 (2.4) <0.01 
History of childhood Trauma (CTQ), N (%) 3 (17.7) 18 (69.2) <0.01 
SAI, Mean (SD) 6.6 (4.7) 26.3 (7.2) <0.01 
Ruminations scale, Mean (SD) 31.0 (12.2) 89.3 (77.4) <0.01 
Life events score (RLCQ), Mean (SD) 114.5 (227.6) 384.0 (321.5) <0.01 
History of severe life events (RLCQ) (last 3 
months), N (%) 
3 (17.7) 20 (76.9) <0.01 
Number of Hassles (last month), Mean (SD) 22.3 (26.3) 100.0 (95.9) <0.01 
Number of Severe Hassles (last month), N 
(%) 
1 (5.9) 11 (42.3) 0.01 
Length of fingernails (mm), Mean (SD) 1.6 (0.5) 2.0 (0.9) 0.09 
Waist circumference (cm), Mean (SD) 83.2 (12.0) 89.3 (16.0) 0.18 
BMI (Kg/m2), Mean (SD) 24.8 (3.7) 26.9 (6.0) 0.21 
 
 
a
: t-test for continuous variable, Chi-squared for categorical variables. HAMD-17: 17-item Hamilton Depression 
Rating Scale; QIDS: 16-ite, Quick Inventory of Depressive Symptoms; NDDS: Newcastle Depression Diagnostic 
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Scale; HCL-33: 33-item Hypomania Checklist; SAI: Self Assessment of Irritability Scale; CTQ: Childhood 
trauma questionnaire; RLCQ: Recent Life Change Questionnaire; YMRS: Young Mania Rating Scale; BMI: Body 
Mass Index. 
Table 2: Generalised linear model analysis between illness variables and fingernail cortisol 
concentration in MDE participants 
 
 Variable   Crude   Adjusted  
   β P value CI β P value CI 
Illness onset (years)  -0.02 0.25 -0.05; 0.01 0.02 0.38 -0.05; 0.02 
Number past episodes  -0.10 0.37 -0.07; 0.02 -0.01 0.59 -0.05; 0.03 
Number past admissions -0.02 0.89 -1.49; 1.29 0.09 0.88 -1.02; 1.19 
Duration of the episode (weeks) <0.01 0.98 0.01; 0.01 <-0.01 0.73 <-0.01; <0.01 
Severity of depression 0.09 0.02* 0.01; 0.16 0.05 0.20 -0.03; 0.13 
Fatigue symptoms   -0.05 0.26 -0.14; 0.03 -0.04 *0.04 -0.09; <-0.01 
Anxiety symptoms   0.11 0.05 <-0.01; 0.22 0.06 0.32 -0.06; 0.18 
Melancholic symptoms  0.19 0.01* 0.03; 0.34 0.12 0.17 -0.05; 0.31 
Non-reactive depression∫ 0.90 0.01* 0.2; 1.6 0.88 0.02* 0.08; 1.67 
Simple reactive depression∫ -0.26 0.65 -1.42; 0.89 -0.23 0.75 -1.67; 1.21 
Probable atypical depression∫  -0.28 0.50 -1.11; 0.55 -0.25 0.57 -1.14; 0.63 
Definitive atypical depression∫  -0.15 0.76 -1.19; 0.87 -0.14 0.79 -1.22; 0.93 
Irritability symptoms  -0.05 0.10 -0.12; 0.01 -0.03 0.33 -0.10; 0.03 
Rumination symptoms  <-0.01 0.28 <-0.01; <0.01 <-0.01 0.64 <-0.01; <0.01 
Hypomanic symptoms <-0.03 0.65 -0.18; 0.11 <-0.01 0.92 -0.10; 0.09 
Childhood trauma  -0.45 0.44 -1.60; 0.70 -0.23 0.62 -1.17; 0.70 
Daily hassles  <-0.01 0.65 -0.02; 0.01 <-0.01 0.87 -0.01; 0.01 
Recent Life events   <-0.01 0.06 <-0.01; <0.01 <-0.01 0.23 <-0.01; <0.01 
The β was calculated using GLM with a gamma distribution and a log-link function. Fingernail cortisol 
analysis was adjusted for age and gender. * P value significant at 0.05 and CI does not cross zero. CI: 95% 
Confidence interval. ∫: subtypes of depression based on ADDS scale 
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Figure 1: Distribution of Fingernail cortisol concentration (FCC) in controls and MDE participants 
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Data were significantly skewed (p<0.05) according to the Kolmogorov-Smirnov test. 
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